NWF Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1M Sell
35,725
-983
-3% -$26.2K 0.11% 131
2025
Q4
$914K Buy
36,708
+3,124
+9% +$78.8K 0.1% 137
2025
Q3
$856K Sell
33,584
-4,072
-11% -$101K 0.09% 150
2025
Q2
$913K Buy
37,656
+1,162
+3% +$27.1K 0.11% 137
2025
Q1
$925K Sell
36,494
-5,994
-14% -$157K 0.13% 113
2024
Q4
$1.13M Sell
42,488
-75
-0.2% -$2.03K 0.17% 81
2024
Q3
$1.23M Sell
42,563
-3,775
-8% -$110K 0.18% 95
2024
Q2
$1.3M Sell
46,338
-227
-0.5% -$6.25K 0.21% 81
2024
Q1
$1.29M Buy
46,565
+5,792
+14% +$161K 0.22% 85
2023
Q4
$1.17M Buy
40,773
+2,615
+7% +$79.1K 0.23% 81
2023
Q3
$1.27M Sell
38,158
-297
-0.8% -$10.5K 0.3% 67
2023
Q2
$1.41M Hold
38,455
0.33% 60
2023
Q1
$1.41M Buy
+38,455
New +$1.66M 0.33% 60

Other funds holding PFE

NWF Advisory Services's PFE Position: Q1 2026 in Review

NWF Advisory Services reduced its Pfizer (PFE) stake by 2.7% in Q1 2026, selling an estimated $26.2K and leaving 35,725 shares worth $1M. The position accounts for 0.11% of the portfolio, ranked #131.

NWF Advisory Services first reported a position in PFE in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.41M in Q2 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • NWF Advisory Services held 35,725 shares of Pfizer worth $1M as of Q1 2026.
  • NWF Advisory Services sold 983 Pfizer shares in Q1 2026, an estimated $26.2K.
  • Pfizer made up 0.11% of NWF Advisory Services's portfolio in Q1 2026, its #131 holding.
  • NWF Advisory Services first reported a position in Pfizer in Q1 2023 and has held it in 13 quarters since.
  • NWF Advisory Services's Pfizer position peaked at $1.41M in Q2 2023.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on NWF Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.